Analytica Bio Energy Corp Stock Book Value Per Share
Analytica Bio Energy Corp fundamentals help investors to digest information that contributes to Analytica Bio's financial success or failures. It also enables traders to predict the movement of Analytica Stock. The fundamental analysis module provides a way to measure Analytica Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Analytica Bio stock.
Analytica |
Analytica Bio Energy Corp Company Book Value Per Share Analysis
Analytica Bio's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Analytica Bio Book Value Per Share | (0.01) X |
Most of Analytica Bio's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Analytica Bio Energy Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Analytica Bio Energy Corp is about -0.01 times. This is much lower than that of the sector and significantly lower than that of the Book Value Per Share industry. The book value per share for all United States stocks is notably higher than that of the company.
Analytica Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Analytica Bio's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Analytica Bio could also be used in its relative valuation, which is a method of valuing Analytica Bio by comparing valuation metrics of similar companies.Analytica Bio is currently under evaluation in book value per share category among its peers.
Analytica Fundamentals
| Return On Equity | -16.3 | |||
| Return On Asset | -195.14 | |||
| Profit Margin | 311.56 % | |||
| Operating Margin | (49.59) % | |||
| Current Valuation | 536.46 K | |||
| Shares Outstanding | 29.18 M | |||
| Price To Earning | 0.35 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 202.5 K | |||
| Gross Profit | 62.91 K | |||
| EBITDA | (95.25 K) | |||
| Net Income | 630.92 K | |||
| Cash And Equivalents | 13.74 K | |||
| Total Debt | 316.75 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 138.73 K | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 3.32 | |||
| Market Capitalization | 233.44 K | |||
| Total Asset | 400 K | |||
| Retained Earnings | (4.68 M) | |||
| Working Capital | (556 K) | |||
| Current Asset | 249 K | |||
| Current Liabilities | 805 K | |||
| Z Score | -16.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Analytica Stock
If you are still planning to invest in Analytica Bio Energy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Analytica Bio's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |